Standardization of T1 measurements with MOLLI in differentiation between health and disease – the ConSept study
暂无分享,去创建一个
Tobias Schaeffter | Tobias Voigt | Eike Nagel | Toby Rogers | Islam Mahmoud | E. Nagel | T. Schaeffter | V. Puntmann | T. Voigt | D. Dabir | Valentina O Puntmann | Darius Dabir | I. Mahmoud | T. Rogers
[1] O. Simonetti,et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. , 2000, The New England journal of medicine.
[2] P. Kellman,et al. Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology. , 2012, European heart journal.
[3] Stefan Neubauer,et al. Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold , 2010, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[4] David A Bluemke,et al. T1 mapping of the myocardium: intra-individual assessment of post-contrast T1 time evolution and extracellular volume fraction at 3T for Gd-DTPA and Gd-BOPTA , 2012, Journal of Cardiovascular Magnetic Resonance.
[5] E. Nagel,et al. EuroCMR (European Cardiovascular Magnetic Resonance) registry: results of the German pilot phase. , 2009, Journal of the American College of Cardiology.
[6] J. Schulz-Menger,et al. T1 mapping in patients with acute myocardial infarction. , 2003, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[7] V. Puntmann. How-to guide on biomarkers: biomarker definitions, validation and applications with examples from cardiovascular disease , 2009, Postgraduate Medical Journal.
[8] E. Nagel,et al. Native Myocardial T1 Mapping by Cardiovascular Magnetic Resonance Imaging in Subclinical Cardiomyopathy in Patients With Systemic Lupus Erythematosus , 2013, Circulation. Cardiovascular imaging.
[9] M. Robson,et al. Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. , 2013, JACC. Cardiovascular imaging.
[10] Stefan Neubauer,et al. Myocardial Tissue Characterization Using Magnetic Resonance Noncontrast T1 Mapping in Hypertrophic and Dilated Cardiomyopathy , 2012, Circulation. Cardiovascular imaging.
[11] E. Nagel,et al. Usefulness of Cardiac Magnetic Resonance in Early Assessment of Cardiomyopathies: Myocardial Fibrosis Is a Common Denominator , 2012, Current Cardiovascular Imaging Reports.
[12] David A Bluemke,et al. T1 mapping of the myocardium: Intra-individual assessment of the effect of field strength, cardiac cycle and variation by myocardial region , 2012, Journal of Cardiovascular Magnetic Resonance.
[13] R. Boellaard,et al. Perfusable tissue index as a potential marker of fibrosis in patients with idiopathic dilated cardiomyopathy. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[14] S. Plein,et al. Myocardial T1 mapping: Application to patients with acute and chronic myocardial infarction , 2007, Magnetic resonance in medicine.
[15] Peter Kellman,et al. Extracellular volume fraction mapping in the myocardium, part 2: initial clinical experience , 2012, Journal of Cardiovascular Magnetic Resonance.
[16] Reza Razavi,et al. Interleaved T1 and T2 relaxation time mapping for cardiac applications , 2009, Journal of magnetic resonance imaging : JMRI.
[17] B R Rosen,et al. Assessment of myocardial ischemia with proton magnetic resonance: effects of a three hour coronary occlusion with and without reperfusion. , 1985, Circulation.
[18] David M Higgins,et al. Modified Look‐Locker inversion recovery (MOLLI) for high‐resolution T1 mapping of the heart , 2004, Magnetic resonance in medicine.
[19] Reza Razavi,et al. Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. , 2013, JACC. Cardiovascular imaging.
[20] P. Kellman,et al. Myocardial extravascular extracellular volume fraction measurement by gadolinium cardiovascular magnetic resonance in humans: slow infusion versus bolus , 2011, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[21] K P Pruessmann,et al. Sensitivity encoded cardiac MRI. , 2001, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[22] Andreas Greiser,et al. Optimization and validation of a fully‐integrated pulse sequence for modified look‐locker inversion‐recovery (MOLLI) T1 mapping of the heart , 2007, Journal of magnetic resonance imaging : JMRI.
[23] Eckart Fleck,et al. Left ventricular chamber dimensions and wall thickness by cardiovascular magnetic resonance: comparison with transthoracic echocardiography. , 2013, European heart journal cardiovascular Imaging.
[24] Roderic I Pettigrew,et al. Effect of Gd‐DTPA‐BMA on blood and myocardial T1 at 1.5T and 3T in humans , 2006, Journal of magnetic resonance imaging : JMRI.
[25] Sandeep N. Gupta,et al. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. , 2008, Journal of the American College of Cardiology.
[26] D. Bluemke,et al. Diffuse myocardial fibrosis evaluation using cardiac magnetic resonance T1 mapping: sample size considerations for clinical trials , 2012, Journal of Cardiovascular Magnetic Resonance.
[27] E. Nagel,et al. Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols , 2008, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.